NEW YORK — Invicro said on Monday that it has partnered with the Yale University School of Medicine to refine an imaging-based tissue biomarker detection technology for clinical pathology applications.
Under the deal, Invicro — a Boston-based subsidiary of Konica Minolta — will work with Yale pathologist David Rimm to advance Quanticell, a technology that uses photostable and bright phosphor-integrated dots for quantitative, amplification-free detection of proteins at cellular and subcellular levels.